Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: Pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS

Biomarkers

Volumn 17, Issue 3, 2012, Pages 223-230

  Musharraf, Syed G ^a   Hashmi, Naghma ^a   Choudhary, M Iqbal ^a   Rizvi, Nadeem ^b   Usman, Ahmed ^b   Atta Ur Rahman, ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

Author keywords

C 18 magnetic bead; ClinProTools software; Lung cancer; MALDI TOF MS; Pattern based profiling; Plasma peptide; Smokers

Indexed keywords

PEPTIDE; PROTEIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; FRACTIONATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PATTERN BASED PEPTIDE PROFILING; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SMOKING; STATISTICAL ANALYSIS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; SMOKING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84860354958     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.657245     Document Type: Article

References (27)

1. Chang JT, Chen LC, Wei SY, Chen YJ, Wang HM, Liao CT. (2006). Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry-plasma peptidomes from nasopharyngeal cancer patients for example. Clin Biochem 39:1144-1151. (Pubitemid 44838573)
2. Cheng AJ, Chen LC, Chien KY, Chen YJ, Chang JTC, Wang HM. (2005). Oral cancer plasma tumor marker identified with beadbased affinity-fractionated proteomic technology. Clin Chem 51:2236-2244.
3. Fan DM, Shi HR, Chen ZM, Wu QH, Liu HN, Zhang RT. (2010). Early detection of ovarian carcinoma by proteome profiling based on magnetic bead separation and matrix-assisted laser desorption/ ionization time of flight mass spectrometry. Afr J Microbiol Res 4:940-951.
4. Flanagan N. (2007). Magnetic beads for biomarker discovery. Genetic Eng Biotech News 27: [Online] Available at: http://www. genengnews.com/gen-articles/ magnetic-beads-for-biomarkerdiscovery/ 2167/
5. Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC, Schraff S, Semmes OJ, Trad WJ, Drake RR. (2008). Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and post treatment head and neck cancer samples. Laryngoscope 18:61-68.
6. Goldman R, Ressom HW, Abdel-Hamid M, Goldman L, Wang A, Varghese RS, An Y, Loffredo CA, Drake SK, Eissa SA, Gouda I, Ezzat S, Moiseiwitsch FS. (2007). Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum. Carcinogenesis 28:2149-2153. (Pubitemid 47543375)
7. GLOBOCAN 2008, IARC, 2010 - GLOBOCAN: Country Fast Stat http:// globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=586
8. Jacobs DR, Adachi H, Mulder I, Kromhout D, Menotti A, Nissinen A, Blackburn H. (1999). Cigarette smoking and mortality risk: Twentyfive- year follow-up of the seven countries study. Arch Intern Med 159:733-740. (Pubitemid 29177664)
9. Jacot W, Lhermitte L, Dossat N, Pujol JL, Molinari N, Daurès JP, Maudelonde T, Mangé A, Solassol J. (2008). Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes. J Thorac Oncol 3:840-850.
10. Jemal A, Center MM, DeSantis C, Ward EM. (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19:1893-1907.
11. Jimenez CR, Filali ZE, Knol JC, Hoekman K, Kruyt FAE, Giaccone G, Smit AB, Li KW. (2007). Automated serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS. Proteomics Clin Appl 1:598-604.
12. Lin XL, Yang SY, Du J, Tian YX, Bu LN, Huo SF, Wang FP, Nan YD. (2010). Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization timeof- flight mass spectrometry serum protein profiling. Chin Med J 123:34-39.
13. Liu C, Pan C, Shen J, Wang H, Yong L. (2011). MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer. Int J Med Sci 8:39-47.
14. Mascaux C, Peled N, Garg K, Kato Y, Wynes MW, Hirsch FR. Early detection and screening of lung cancer. (2010). Expert Rev Mol Diagn 10:799-815.
15. Orvisky E, Drake SK, Martin BM, Abdel-Hamid M, Ressom HW, Varghese RS, An Y, Saha D, Hortin GL, Loffredo CA, Goldman R. (2006). Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. Proteomics 6:2895-2902.
16. Proctor RN. Tobacco and the global lung cancer epidemic. (2001). Nat Rev Cancer 1:82-86. (Pubitemid 33741884)
17. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, Mehigh RJ, Cockrill SL, Scott GB, Tammen H, Schulz-Knappe P, Speicher DW, Vitzthum F, Haab BB, Siest G, Chan DW. (2005). HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5:3262-3277. (Pubitemid 41192034)
18. Sasco AJ, Secretan MB, Straif K. (2004). Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45:3-9.
19. Schwamborn K, Krieg RC, Grosse J, Reulen N, Chen RW, Knuechel R, Jakse G, Henkel C. (2009). Serum proteomic profiling in patients with bladder cancer. Eur Urol 56:989-996.
20. Shevchenko VE, Aronotskaya NE, Zaridze DG. (2010). Detection of lung cancer using plasma protein profiling by matrix- assisted laser desorption/ionization time-of-flight mass spectrometry. Eur J mass spectrum (Chichester En.) 16:539-549.
21. Sven B, Uta C, Georg MF, Jan L, Alexander L, Joachim T. (2005). Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time of flight mass spectrometry. Clin Chem 51:973-988.
22. Villanueva J, Martorella AJ, Lawlor K, Philip J, Fleisher M, Robbins RJ, Tempst P. (2006a). Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol Cell Proteomics 5:1840-1852. (Pubitemid 44688193)
23. Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, Holland EC, Tempst P. (2004). Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Ana Chem 76:1560-1570. (Pubitemid 38338398)
24. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB. (2006b). Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 116:271-284. (Pubitemid 43121812)
25. Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, Sharma S, Dubinett SM. (2008). Smoking and lung cancer. The role of inflammation. Proc Am Thorac Soc 5:811-815.
26. Wong MYM, Yu KOY, Poon TCW, Ang IL, Law MK, Chan KYW, Ng EWY, Ngai SM, Sung JJY, Chan HLY. (2010). Magnetic bead-based serum proteomic fingerprinting method for parallel analytical analysis and micro preparative purification. Electrophoresis 31: 1721-1730.
27. Yildiz PB, Shyr Y, Rahman JS, Wardwell NR, Zimmerman LJ, Shakhtour B, Gray WH, Chen S, Li M, Roder H, Liebler DC, Biqbee WL, Sieqfried JM, Weissfeld JL, Gonzalez AL, Ninan M, Johnson DH, Carbone DP, Caprioli RM, Massion, PP. (2007). Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol 2:893-901. (Pubitemid 47511591)